People · Operator
Named in public records as an officer, director or promoter · active 2017–2017 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Grail, Inc. | — | Biotechnology | Growth/Late | $2.2B | $2.9B | 2017 |
Jose T. Baselga at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Jose T. Baselga on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Robert Nelsen | 1 | 22 |
| Richard Klausner | 1 | 7 |
| Robert T. Nelsen | 1 | 5 |
| MIN CUI | 1 | 5 |
| William Rastetter | 1 | 4 |
| Catherine Friedman | 1 | 3 |
| Hans Bishop | 1 | 3 |
| Jeffrey T. Huber | 1 | 2 |
| William T. Rastetter | 1 | 2 |
| MAYKIN HO | 1 | 2 |
| JEFFREY HUBER | 1 | 2 |
| Steve Mizell | 1 | 1 |
| William Chase | 1 | 1 |
| Robert Ragusa | 1 | 1 |
| Kaye T. Foster-Cheek | 1 | 1 |
| Aaron Freidin | 1 | 1 |
| Sarah Krevans | 1 | 1 |
| HAL BARRON | 1 | 1 |
| KAYE FOSTER | 1 | 1 |
| Kaye T. Foster | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.